Biopharmaceutical Manufacturing
NovaBiopharma Cuts CSV Cycle Time by 68% and Passes FDA Inspection with Zero Findings
A mid-size biopharma manufacturer achieved full inspection readiness across 12 GxP systems in 6 weeks — eliminating traceability gaps and reducing audit preparation time by 74%.
68%Faster validation
0FDA 483 findings
6 weeksTo inspection readiness
FDA 21 CFR Part 11GAMP 5IQ/OQ/PQPre-Approval Inspection
Read full case study